Treatment of life-threatening type I refractory coeliac disease with long-term infliximab

Digestive and Liver Disease

Volumn 40, Issue 1, 2008, Pages 74-77

  Costantino, G ^a   della Torre, A ^a   Lo Presti, M A ^a   Caruso, R ^a   Mazzon, E ^a,b   Fries, W ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Institute for Health Care and Medical Research Bonino Pulejo   (Italy)

Author keywords

Infliximab; Refractory coeliac disease; Therapy; TNF

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; PREDNISONE;

AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CELIAC DISEASE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; FOLLOW UP; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PHYSICAL EXAMINATION; RECURRENT DISEASE; SEROLOGY; SINGLE DRUG DOSE; TREATMENT FAILURE;

AGED; ANTIBODIES, MONOCLONAL; CAPSULE ENDOSCOPY; CELIAC DISEASE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37048999189     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.10.017     Document Type: Article

References (17)

1. Daum S., Cellier C., and Mulder C.J.J. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 19 (2005) 413-424
2. Gillett H.R., Arnott I.D.R., McIntyre M., Campbell S., Dahele A., Priest M., et al. Successful infliximab treatment for steroid-refractory coeliac disease: a case report. Gastroenterology 122 (2002) 800-805
3. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337 (1997) 1029-1035
4. Borelli O., Bascetti C., Viola F., Bueno de Mesquita M., Barbato M., Mancini V., et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 36 (2004) 342-347
5. Rutgeerts P., Sandborn W.J., Feagan B.G., Reinisch W., Olson A., Johanns J., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 (2005) 2462-2476
6. Rossetti S., Actis G.C., Fadda M., Rizzetto M., and Palmo A. The use of anti-tumour necosis monoclonal antibody - infliximab - to treat ulcerative colitis: implications and trends beyond the available data. Dig Liver Dis 36 (2004) 426-431
7. Lu{combining double acute accent}gering A., Schmidt M., Lu{combining double acute accent}gering N., Pauels H.G., Domschke W., and Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase dependent pathway. Gastroenterology 121 (2001) 1145-1157
8. Ten Hove T., van Montfrans C., Peppelenbosch M.P., and van Deventer S.J. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 50 (2002) 206-211
9. Di Sabatino A., Ciccocioppo R., Cinque B., Millimaggi D., Morera R., Ricevuti L., et al. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut 53 (2004) 70-77
10. Cellier C., Delabesse E., Helmer C., Patey N., Matuchansky C., Jabri B., et al. Refractory sprue, coeliac disease, and entheropathy-associated T-cell lymphoma. French Coeliac Dis Study Group. Lancet 356 (2000) 203-208
11. Wahab P.J., Crusius J.B.A., Meijer J.W.R., Uil J.J., and Mulder. Cyclosporin in the treatment of adults with refractory coeliac disease-an open pilot study. Aliment Pharmacol Ther 14 (2000) 767-774
12. Bernstein E.F., and Whitington P.F. Successful treatment of atypical sprue in an infant with cyclosporine. Gastroenterology 95 (1988) 199-204
13. Lomgstreth G.F. Successful treatment of refractory sprue with cyclosporine. Ann Intern Med 119 (1993) 1014-1016
14. Mulder C.J., Wahab P.J., Meijer J.W.R., and Metselaar E. A pilot study of recombinant human interleukin-10 in adults with refractory celiac disease. Eur J Gastroenterol Hepatol 13 (2001) 1183-1188
15. Mauriño E., Niveloni S., Cherñavsky A., Pedreira S., Mazure R., Vazquez H., et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 97 (2002) 2595-2602
16. Abdulkarim A.S., Burgart L.J., See J., and Murray J.A. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97 (2002) 2016-2021
17. Goerres M.S., Meijer J.W.R., Wahab P.J., Kerckhaert J.A.M., Groenen P.J.T.A., Van Krieken J.H.J.M., et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 18 (2003) 487-494